Several studies reveal Nidogen-Laminin interactions as basis for the important role for Nidogen-2 (NID-2) during cancer metastasis and NID-2 has been recently identified as a suitable biomarker for cancer progression (Chettiankandy et al., 2022). This evidence concerns the gene NID2 and cancer.